ArticleDiscover oncology2026

A novel mitochondrial-associated risk score reveals a potential link between pancreatic ductal adenocarcinoma and chemotherapy resistance as well as poor response to immunotherapy.

Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.